<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35569080</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1573-4919</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Molecular and cellular biochemistry</Title>
          <ISOAbbreviation>Mol Cell Biochem</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Role of curcumin in ameliorating hypertension and associated conditions: a mechanistic insight.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11010-022-04447-8</ELocationID>
        <Abstract>
          <AbstractText>Curcumin, belongs to the curcuminoid family, is a natural phenolic compound, presenting low bioavailability and pleiotropic activity. Since ancient times, curcumin has been in use as food spices and folk remedy to treat cough, cold, cuts and wounds, and skin diseases. Preclinical and clinical studies have indicated that curcumin acts a promising therapeutic agent in the management of a wide array of health issues, viz., hyperlipidemia, metabolic syndrome, anxiety, arthritis, cancer and inflammatory diseases. Owing to its enormous potential, recent research has been focused on the synthesis of curcumin and its analogues for the management of metabolic disorders. In the current scenario, hypertension is considered as a key risk factor due to its involvement in various pathogeneses. Mechanistically, curcumin and its analogues like hexahydrocurcumin, tetrahydrocurcumin, etc. have been reported to elicit anti-hypertensive effect through diverse signalling pathways, viz., pathway mediated by Nrf2-ARE, NF-kB, NO/cGMP/PDE5/MMPs, RAAS/ACE, HAT/HDAC, G0/G1/apoptosis, CYP3A4, UCP2/PARP, VEGF/STAT/AXL/tyrosine kinase and TGF-β/Smad-mediated pathways. Thus, the present review has been aimed to highlight different molecular pathways involved in the amelioration of hypertension and associated conditions.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Joshi</LastName>
            <ForeName>Priyanka</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan, 304022, India.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>R&amp;D, Patanjali Ayurved Ltd, Patanjali Food and Herbal Park, Haridwar, Uttarakhand, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Joshi</LastName>
            <ForeName>Sushil</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>R&amp;D, Patanjali Ayurved Ltd, Patanjali Food and Herbal Park, Haridwar, Uttarakhand, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Semwal</LastName>
            <ForeName>Deepak Kumar</ForeName>
            <Initials>DK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Phytochemistry, Faculty of Biomedical Sciences, Uttarakhand Ayurved University, Harrawala, Dehradun, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Verma</LastName>
            <ForeName>Kanika</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan, 304022, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dwivedi</LastName>
            <ForeName>Jaya</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry, Banasthali Vidyapith, Banasthali, Rajasthan, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sharma</LastName>
            <ForeName>Swapnil</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0003-2639-7096</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan, 304022, India. skspharmacology@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Mol Cell Biochem</MedlineTA>
        <NlmUniqueID>0364456</NlmUniqueID>
        <ISSNLinking>0300-8177</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Anti-hypertensive activity</Keyword>
        <Keyword MajorTopicYN="N">Curcumin</Keyword>
        <Keyword MajorTopicYN="N">Nitric oxide</Keyword>
        <Keyword MajorTopicYN="N">Oxidative stress</Keyword>
        <Keyword MajorTopicYN="N">Turmeric</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>15</Day>
          <Hour>13</Hour>
          <Minute>50</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35569080</ArticleId>
        <ArticleId IdType="doi">10.1007/s11010-022-04447-8</ArticleId>
        <ArticleId IdType="pii">10.1007/s11010-022-04447-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Touyz RM, Schiffrin EL (2004) Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 122:339–352</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15338229</ArticleId>
            <ArticleId IdType="doi">10.1007/s00418-004-0696-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duron E, Hanon OV (2008) Vascular risk factors, cognitve decline, and dementia. Vasc Health and Risk Manag 4:363–381</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/VHRM.S1839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toth P, Tarantini S, Ashpole NM, Tucsek Z, Milne GL, Valcarcel-Ares NM, Menyhart A, Farkas E, Sonntag WS, Csiszar A, Ungvari Z (2015) IGF-1 deficiency impairs neurovascular coupling in mice: implications for cerebromicrovascular aging. Aging Cell 14:1034–1044</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26172407</ArticleId>
            <ArticleId IdType="pmc">4693458</ArticleId>
            <ArticleId IdType="doi">10.1111/acel.12372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Senoner T, Wolfgang D (2020) Variability in biological markers for prediction of adverse cardiovascular events. Heart 106(14):1040–1040</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32303629</ArticleId>
            <ArticleId IdType="doi">10.1136/heartjnl-2020-316717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boonla O et al (2014) Curcumin improves endothelial dysfunction and vascular remodeling in 2K–1C hypertensive rats by raising nitric oxide availability and reducing oxidative stress. Nitric Oxide 42:44–53</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25194767</ArticleId>
            <ArticleId IdType="doi">10.1016/j.niox.2014.09.001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhuang X, Liao L, Dong X, Hu X, Guo Y, Du Z, Liao X, Wang L (2016) Design, synthesis, and antihypertensive activity of curcumin-inspired compounds via ACE inhibition and vasodilation, along with a bioavailability study for possible benefit in cardiovascular diseases. Drug Des Devel Ther 10:129–139</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26792980</ArticleId>
            <ArticleId IdType="pmc">4708961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alamgir ANM (2017) Therapeutic use of medicinal plants and their extracts Cham, Springer, Pharmacognosy 61–104</Citation>
        </Reference>
        <Reference>
          <Citation>Cione E, La Torre C, Cannataro R, Caroleo MC, Plastina P, Gallelli L (2020) Quercetin, epigallocatechin gallate, curcumin, and resveratrol: from dietary sources to human MicroRNA modulation. Molecules 25:1–21</Citation>
        </Reference>
        <Reference>
          <Citation>Ghayur MN, Gilani AH, Afridi MB (2005) Cardiovascular effects of ginger aqueous extract and its phenolic constituents are mediated through multiple pathways. Vasc Pharmacol 43:234–241</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vph.2005.07.003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akinyemi AJ, Thome GR, Morch VM, Stefanello N, Goulare JF, Bello-Klein A, Oboh G, Schetinger MRC (2015) Effect of dietary supplementation of ginger and turmeric rhizomes on angiotensin-1 converting enzyme (ACE) and arginase activities in L-NAME induced hypertensive rat. J Funct Foods 17:792–801</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jff.2015.06.011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joshi P, Joshi S, Semwal D, Bisht A, Paliwal S, Dwivedi J, Sharma S (2021) Curcumin: An Insight to molecular pathways involved in anti-cancer activity. Mini-Rev Med Chem 21:1–38 ((In Press))</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1389557521666210122153823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joshi P, Joshi S, Semwal DK, Bisht A, Sharma S, Dwivedi J (2021) Chemical composition, antioxidative and antimicrobial activities of turmeric spent oleoresin. Ind Crops and Prod 162:113278</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.indcrop.2021.113278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Priyadarsini KI (2009) Photophysics, photochemistry and photobiology of curcumin: studies from organic solutions, bio-mimetics and living cells. J Photochem Photobiol C: Photochem Rev 10:81–95</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jphotochemrev.2009.05.001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderson WP, Kett MM, Stevenson KM, Edgley AJ, Denton KM, Fitzgerald SM (2000) Renovascular hypertension: structural changes in the renal vasculature. Hypertension 36:648–652</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11040252</ArticleId>
            <ArticleId IdType="doi">10.1161/01.HYP.36.4.648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Humphrey JD (2008) Mechanisms of arterial remodeling in hypertension; Coupled roles of wall shear and intramural stress. Hypertension 52:195–200</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18541735</ArticleId>
            <ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.107.103440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lemarie CA, Tharaux PL, Lehoux S (2010) Extracellular matrix alterations in hypertensive vascular remodelling. J Mol Cell Cardiol 48:433–439</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19837080</ArticleId>
            <ArticleId IdType="doi">10.1016/j.yjmcc.2009.09.018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderson JL, Morrow DA (2017) Acute myocardial infarction. N Engl J Med 25:2053–2064</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMra1606915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jordan JD, Powers WJ (2016) Acute Blood pressure management after ischemic stroke. Hypert Stroke 151–162</Citation>
        </Reference>
        <Reference>
          <Citation>Ogah OS, Okpechi I, Chukwuonye II, Akinyemi JO, Onwubere BJ, A.O Falase AO, Stewart S, Silwa K, (2012) Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: A review. W J Cardiol 4:327</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4330/wjc.v4.i12.327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel P, Ordunez P, Connell K, Lackland D, Dipette D (2017) An update: standardized hypertension management to reduce cardiovascular disease morbidity and mortality worldwide. Insights in Blood Pressure 3:327</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.21767/2471-9897.1000015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dollery CM, Mcewan JR, Henney AM (1995) Matrix metalloproteinase and cardiovascular disease. Circ Res 77:863–868</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7554139</ArticleId>
            <ArticleId IdType="doi">10.1161/01.RES.77.5.863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee MY, Griendling KK (2008) Redox signaling, vascular function and hypertension. Antioxid Redox Signal 10:1045–1059</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18321201</ArticleId>
            <ArticleId IdType="pmc">2828811</ArticleId>
            <ArticleId IdType="doi">10.1089/ars.2007.1986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sreejeevan RM (1996) Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol 49:105–107</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.2042-7158.1997.tb06761.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dinkova-Kostova AT, Talalay P (2008) Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol Nutr Food Res 52:S128–S138</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18327872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tapia E, Soto V, Ortiz-vega KM, Zarco-Marquez G, Molina-jijon E, Cristobal-Garcia M, Santamaria J, Garcia-Nino WR, Correa F, Zazueta C, Pedraza-Chaverri J (2012b) Curcumin Induces Nrf2 Nuclear Translocation and Prevents Glomerular Hypertension, Hyperfiltration, Oxidant stress and the decrease in Antioxidant Enzymes in 5/6 Nephrectomised Rats. Oxid Med Cellul Longev 269039</Citation>
        </Reference>
        <Reference>
          <Citation>Kim HJ, Vaziri ND (2010) Contribution of impaired Nrf2-Leap 1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol 298:F662–F671</Citation>
        </Reference>
        <Reference>
          <Citation>Trujillo J, Chrinio YI, Molina-Jijon E, Anderica-Romero AC, Tapia E, Pedraza-Chaverri J (2013) Renoprotective effect of the antioxidant curcumin: Recent findings. Redox Biol 1:448–456</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24191240</ArticleId>
            <ArticleId IdType="pmc">3814973</ArticleId>
            <ArticleId IdType="doi">10.1016/j.redox.2013.09.003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Satarug S, Nishijo M, Ujjin P, Vanavanitkun Y, Moore MR (2005) Cadmium-induced nephropathy in the development of high blood pressure. Toxicol Lett 157:57–68</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15795094</ArticleId>
            <ArticleId IdType="doi">10.1016/j.toxlet.2005.01.004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eum KD, Lee MS, Paek D (2008) Cadmium in blood and hypertension. Sci Total Environ 407:147–153</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18845316</ArticleId>
            <ArticleId IdType="doi">10.1016/j.scitotenv.2008.08.037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee BK, Kim Y (2012) Association of blood cadmium with hypertension in the Korean general population. Analysis of the 2008–2010 Korean national health and nutrition examination survey data. Am J Ind Med 55:1060–1067</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22692952</ArticleId>
            <ArticleId IdType="doi">10.1002/ajim.22078</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee MS, Park SK, Hu H, Lee S (2011) Cadmium exposure and cardiovascular disease in the 2005 Korea national health and nutrition examination survey. Environ Res 111:171–176</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21055738</ArticleId>
            <ArticleId IdType="doi">10.1016/j.envres.2010.10.006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olsen L, Lind PM, Lind L (2012) Gender differences for associations between circulating levels of metals and coronary risk in the elderly. Int J Hyg Environ Health 215:411–417</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22169700</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ijheh.2011.11.004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tellez-plaza M, Navas-Acien A, Crainiceanu CM, Guallar E (2008) Cadmium exposure and hypertension in the 1999–2004 National health and nutrition examination survey (NHANES). Environ Health Perspect 116:51–56</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18197299</ArticleId>
            <ArticleId IdType="doi">10.1289/ehp.10764</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Fang J, Leonard SS, Rao KM (2004) Cadmium inhibits the electron tranfer chain and induces reactive oxygen species. Free Radic Biol Med 36:1434–1443</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15135180</ArticleId>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2004.03.010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dorta DJ, Leite S, Demarco KC, Prado IM, Rodrigues T, Mingatto FE, Uyemura SA, Santos AC, Curti CA (2003) Proposed sequence of events for cadmium induced mitochondrial impairment. J Inorg Biochem 97:251–257</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14511887</ArticleId>
            <ArticleId IdType="doi">10.1016/S0162-0134(03)00314-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nwokocha CR, Baker A, Douglas D, Mccalla G, Nwokocha M, Brown PD (2013) Apocynin ameliorates cadmium-induced hypertension through elevation of endothelium nitric oxide synthase. Cardiovasc Toxicol 13:357–363</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23703608</ArticleId>
            <ArticleId IdType="doi">10.1007/s12012-013-9216-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sompamit K, Kukongviriyapan U, Donpunha W, Nakmareong S, Kukongviriyapan V (2010) Reversal of cadmium-induced vascular dysfunction and oxidative stress by meso-2,3- dimercaptosuccinic acid in mice. Toxicol Lett 198:77–82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20399841</ArticleId>
            <ArticleId IdType="doi">10.1016/j.toxlet.2010.04.007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoopan N, Watcharasit P, Wongsawatkul O, Piyachaturawat P, Sarayavivad J (2008) Attenuation of eNOS expression in cadium-induced hypertensive rats. Toxicol Lett 176:157–161</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18155860</ArticleId>
            <ArticleId IdType="doi">10.1016/j.toxlet.2007.11.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oner G, Senturk UK, Izgut-Uysal N (1995) The role of cadmium in the peroxidative response of kidney to stress. Biol Trace Elem Res 48:111–117</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7626368</ArticleId>
            <ArticleId IdType="doi">10.1007/BF02789083</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Skoczynska A, Martynowicz H (2005) The impact of subchronic cadmium poisoning on the vascular effect of nitric oxide in rats. Hum Exp Toxicol 24:353–361</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16119249</ArticleId>
            <ArticleId IdType="doi">10.1191/0960327105ht536oa</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cuypers A, Plusquin M, Remans T, Jozefczak M, Keunen E, Gielen H, Opdenakker K, Nair AR, Munters E, Artois TJ, Nawrot T, Vangronsveld J, Smeets K (2010) Cadmium stress: an oxidative challenge. Biometals 5:927–940</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10534-010-9329-x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nair AR, DeGheselle O, Smeets K, Kerkhove EV, Cuypers A (2013) Cadmium-induced pathologies: where is the oxidative balance lost (or Not)? Int J Mol Sci 14:6116–6143</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23507750</ArticleId>
            <ArticleId IdType="pmc">3634456</ArticleId>
            <ArticleId IdType="doi">10.3390/ijms14036116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Waisberg M, Joseph P, Hale B, Beyermann D (2003) Molecular and cellular mechanisms of cadmium carcinongenesis. Toxicol 192:95–117</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0300-483X(03)00305-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bagchi D, Vuchetich PJ, Bagchi M, Hassoun EA, Tran MX, Tang L, Stohs SJ (1997) Induction of oxidative stress by chronic administration of sodium dichromate [chromium VI] and cadmium chloride [cadmium II] to rats. Free Radic Biol Med 22:471–478</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8981039</ArticleId>
            <ArticleId IdType="doi">10.1016/S0891-5849(96)00352-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu F, Jan KY (2000) DNA damage in arsenite and cadmium treated bovine aortic endothelial cells. Free Radic Biol Med 28:55–63</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10656291</ArticleId>
            <ArticleId IdType="doi">10.1016/S0891-5849(99)00196-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kusaka Y, Kelly RA, Williams GH, Kifor I (2000) Coronary microvascular endothelial cells cosecrete angiotensin II and endothelin-I via a regulated pathway. Am J Physiol Heart Circ Physiol 279:H1087–H1096</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10993771</ArticleId>
            <ArticleId IdType="doi">10.1152/ajpheart.2000.279.3.H1087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prozialeck WC, Niewenhuis RJ (1991) Cadmium (Cd<sup>2+</sup>) disrupts Ca(2+)-dependent cell-cell junctions and alters the pattern of E-cadherin immunofluorescence in LLC-PK1 cells. Biochem Biophys Res Commun 181:1118–1124</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1764062</ArticleId>
            <ArticleId IdType="doi">10.1016/0006-291X(91)92054-N</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prozialeck WC (2000) Evidence that E-cadherin may be a target for cadmiumtoxicity in epithelial cells. Toxicol Appl Pharmacol 164:231–249</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10799334</ArticleId>
            <ArticleId IdType="doi">10.1006/taap.2000.8905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prozialeck WC, Edwards JR, Woods JM (2006) The vascular endothelium as a target of cadmium toxicity. Life Sci 79:1493–1506</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16765992</ArticleId>
            <ArticleId IdType="doi">10.1016/j.lfs.2006.05.007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Washington B, Williams S, Armstrong P, Mtshali C, Robinson JT, Myles EL (2006) Cadmium toxicity on arterioles vascular smooth muscle cells of spontaneously hypertensive rats. Int J Environ Res Public Health 3:323–328</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17159273</ArticleId>
            <ArticleId IdType="doi">10.3390/ijerph2006030040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thimmulappa RK, Lee H, Rangasamy T, Reddy SP, Yamamoto M, Kensler TW, Biswal S (2006) Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Investig 116:984–995</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16585964</ArticleId>
            <ArticleId IdType="pmc">1421348</ArticleId>
            <ArticleId IdType="doi">10.1172/JCI25790</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heiss EH, Schachner D, Werner ER, Dirsch VM (2009) Active NF-E2-related factor (Nrf2) contributes to keep endothelial NO synthase (eNOS) in the coupled state; role of reactive oxygen species (ROS), eNOS and heme oxygenase (HO-1) levels. J Biol Chem 284:31579–31586</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19797052</ArticleId>
            <ArticleId IdType="pmc">2797228</ArticleId>
            <ArticleId IdType="doi">10.1074/jbc.M109.009175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garcia-Nino WR, Pedraza-Chaverri J (2014) Protective effect of curcumin against heavy metal induced liver damage. Food Chem Toxicol 69:182–201</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24751969</ArticleId>
            <ArticleId IdType="doi">10.1016/j.fct.2014.04.016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rahman I, Biswas SK, Kirkham PA (2006) Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol 72:1439–1452</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16920072</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bcp.2006.07.004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh S, Aggarwal BB (1995) Activation of transcription factor NF-KappaB is suppressed by curcumin (Diferuloymethane). J Biol Chem 270:24995–25000</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7559628</ArticleId>
            <ArticleId IdType="doi">10.1074/jbc.270.42.24995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, Sethi G, Limtrakul P, Badmaev V, Aggarwal BB (2007) Curcumin, Demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 28:1733–1765</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/carcin/bgm123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Somparn P, Phisalaphong C, Nakornchai S, Unchern S, Morales NP (2007) Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biol Pharm Bull 30:74–78</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17202663</ArticleId>
            <ArticleId IdType="doi">10.1248/bpb.30.74</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kukongviriyapan U, Pannangpetch P, Kukongviriyapan V, Donpunha W, Sompait K, Surawattanwan P (2014) Curcumin protects cadmium induced vascular dysfunction, hypertension and tissue cadmium accumulation in mice. Nutrients 6:1194–1208</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24662163</ArticleId>
            <ArticleId IdType="pmc">3967187</ArticleId>
            <ArticleId IdType="doi">10.3390/nu6031194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eybl V, Kotyzova D, Koutensky J (2006) Comparative study of natural antioxidant-curcumin, reveratrol and melatonin inn cadmium-induced oxidative damage in mice. Toxicology 225:150–156</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16806632</ArticleId>
            <ArticleId IdType="doi">10.1016/j.tox.2006.05.011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cohly HHP, Taylor A, Angel MF, Salahudeen AK (1998) Effect of turmeric, turmerin and curcumin on H<sub>2</sub>O-induced renal epithelial (LLC-PKI) cell injury. Free Rad Biol Med 24:49–54</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9436613</ArticleId>
            <ArticleId IdType="doi">10.1016/S0891-5849(97)00140-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cuadrado A, Moreno-Murciano P, Pedraza-Chaverri KJ (2009) The transaction factor Nrf2 as a new therapeutic target in parkinson’s disease. Expert Opin Ther Targets 13:319–329</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19236154</ArticleId>
            <ArticleId IdType="doi">10.1517/13543780802716501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guyton AC, Hall JE (2011) Textbook of Medical Physiology Elsevier, Philadelphia Saunders</Citation>
        </Reference>
        <Reference>
          <Citation>Kansanen E, Jyrkkanen HK, Levonen L (2012) Activation of stress signaling pathways by electrophilic oxidized and nitrated lipids. Free Rad Biol Med 52:973–982</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22198184</ArticleId>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2011.11.038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanchez M, Galiesto M, Vera R, Villar IC, Zarzuelo A, Tamargo J et al (2006) Quercetin downregulates NADPH oxidase increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 24:75–84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16331104</ArticleId>
            <ArticleId IdType="doi">10.1097/01.hjh.0000198029.22472.d9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderson S, Renake HG, Brenner BM (1986) Antihypertensive therapy must control glomerular hypertension to limit glomerular injury. J Hypert 4:S242–S244</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00004872-198602000-00016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cruz R, Correa-Rotter DJ, Sanchez-Gonzalez, et al (2007) Renoprotective and antihypertensive effects of S-allycysteine in 5/6 nephrectomized rats. Am J Physiol 293:F1691–F1698</Citation>
        </Reference>
        <Reference>
          <Citation>Sanchez-Lozada LG, Tapia E, Santamaria J et al (2005) Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kid Internat 67:237–247</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1523-1755.2005.00074.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endemann DH, Schiffrin EL (2004) Endothelial dysfunction. J Am Soc Nephrol 15:1983–1992</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15284284</ArticleId>
            <ArticleId IdType="doi">10.1097/01.ASN.0000132474.50966.DA</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Felmeden DC, Lip GYH (2005) Endothelial function and its assessment. Expert Opin Investig Drugs 14:1317–1336</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/13543784.14.11.1319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S (2009) Endothelium dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol 157:527–536</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19630832</ArticleId>
            <ArticleId IdType="pmc">2707964</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1476-5381.2009.00240.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong WT, Tian XY, Chen, et al (2010) Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase -2 upregulation implications on hypertension. Circ Res 107:984–991</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20724703</ArticleId>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.110.222794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong SL, Lau CW, Wong WT et al (2011) Pivotal role of protein kinase Cδ in angiotensin-II induced endothelial cyclooxygenase-2 expression: A link to vascular inflammation. Arteriosc Thromb Vasc Biol 31:1169–1176</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/ATVBAHA.110.216044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kruangtip O, Chootip K, Temkitthawaon P, Changwichit K, Chuprajob T, Changtam C, Suksamrarn A, Khorna N, Schofield CN, Ingkanian K (2015) Curcumin analogues inhibit phosphodiesterase-5 and dilate rat pulmonary arteries. J Pharm Pharmacol 67:87–95</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25176340</ArticleId>
            <ArticleId IdType="doi">10.1111/jphp.12302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mehta PK, Griendling KK (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292:C82–C97</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16870827</ArticleId>
            <ArticleId IdType="doi">10.1152/ajpcell.00287.2006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC et al (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450–454</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14647384</ArticleId>
            <ArticleId IdType="pmc">7095016</ArticleId>
            <ArticleId IdType="doi">10.1038/nature02145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akinyemi AJ, Thome GR, Morsch VM et al (2016) Effect of ginger and turmeric rhizomes on inflammatory cytokines levels and enzymes activities of cholinergic and purinergic systems in hypertensive rats. Planta Med 82:612–620</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27002391</ArticleId>
            <ArticleId IdType="doi">10.1055/s-0042-102062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santos Parker JR, Strahler TR, Bassett CJ, Bispham NZ, Chonchol MB, Seals DR (2017) Curcumin supplementation improves vascular endothelial function in healthy middle aged and older adults by increasing nitric oxide bioavailability and reducing oxidative stress. Aging 9:187–208</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28070018</ArticleId>
            <ArticleId IdType="pmc">5310664</ArticleId>
            <ArticleId IdType="doi">10.18632/aging.101149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leong XF (2018) The spice for hypertension: Protective role of Curcuma longa. Biomed Pharmacol J 11:1829–1840</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.13005/bpj/1555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cai W, Zhu Y, Furuya K, Li Z, Sokabe M, Chen L (2008) Two different molecular mechanisms underlying progesterone neuroprotection against ischemic brian damage. Neuropharmacology 55:12738</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuropharm.2008.04.023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chwalisz K, Garfield RE (1998) Nitric oxide as the final metabolic mediator of cervical ripening. Hum Reprod 13:245–248</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9557812</ArticleId>
            <ArticleId IdType="doi">10.1093/humrep/13.2.245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma B, Singh N (2013) Pharmacological inhibition of inducible nitric oxide synthase (iNOS) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, convalesce behaviour and biochemistry of hypertension induced vascular dementia in rats. Pharmacol Biochem Behav 103:821–830</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23201648</ArticleId>
            <ArticleId IdType="doi">10.1016/j.pbb.2012.11.011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Griffiths MJ, Messent M, MacAllister RJ, Evans TW (1993) Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol 110:963–968</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7507781</ArticleId>
            <ArticleId IdType="pmc">2175814</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1476-5381.1993.tb13907.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ara C, Karabulut AB, Krimlioglu H, Yimlaz M, Kirimliglu V, Yilmaz S (2006) Protective effect of aminoguandine against oxidative stress in an experimental peritoneal adhesion model in rats. Cell Biochem Func 24:443–438</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cbf.1245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R (1995) Anti tumor and antioxidant activity of natural curcuminoids. Cancer Lett 94:79–83</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7621448</ArticleId>
            <ArticleId IdType="doi">10.1016/0304-3835(95)03827-J</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gupta B, Ghosh B (1992) Curcuma longa inhibits TNF-alpha induced expression of adhesion molecules on human umbilical vein endothelial cells. Int J Immunopharmacol 21:745–757</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0192-0561(99)00050-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Binion DG, Otterson MF, Rfalee P (2008) Curcumin inhibits VEGF mediated angiogenesis in human intestinal microvascular endothelial cells through Cox-2 and MAPK inhibition. Gut 57:1509–1517</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18596194</ArticleId>
            <ArticleId IdType="doi">10.1136/gut.2008.152496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J, Dong S (2012) ICAM-1 and IL-8 are expressed by DEHP and suppressed by curcumin through ERK and p38 MAPK in human umbilical vein endothelial cells. Inflammation 35:859–870</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21932059</ArticleId>
            <ArticleId IdType="doi">10.1007/s10753-011-9387-4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baeuerle PA, Henkel T (1994) Function and activation of NF-kappaB in the immune system. Annual Rev Immunol 12:141–179</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.iy.12.040194.001041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan MM (1995) Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol 49:1551–1556</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7786295</ArticleId>
            <ArticleId IdType="doi">10.1016/0006-2952(95)00171-U</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coban D, Milenkovic D, Chanet A, Khallou-Laschet J, Sabbe L, Palagani A et al (2012) Dietary curcumin inhibits atherosclerosis by affecting the expression of genes involved in leukocyte adhesion and transendothelial migration. Mol Nutr Food Res 56:1270–1281</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22753158</ArticleId>
            <ArticleId IdType="doi">10.1002/mnfr.201100818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fuller B, Dijk S, Butler P, Hoang V, Davidson B (2003) Pro-inflammatory agents accumulate during donor liver cold preservation: a study on increased adhesion molecule expression and abrogation by curcumin in cultured endothelial cells. Cryobiology 46:284–288</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12818219</ArticleId>
            <ArticleId IdType="doi">10.1016/S0011-2240(03)00027-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, Gu ZL, Qin ZH, Liang ZQ (2008) Effect of curcumin on the adhesion of platelets to brain microvascular endothelial cells in-vitro. Acta Pharmacol Sin 29:800–807</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18565277</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1745-7254.2008.00813.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kam A, Li KM, Razmovski-Naumovski V et al (2015) Curcumin reduces tumour recrosis factor –enhanced annexin V-positive microparticle release in human vascular endothelial cells. J Pharm Pharm Sci 18:424–433</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26626244</ArticleId>
            <ArticleId IdType="doi">10.18433/J3ZC8G</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Epstein J, Sanderson IR, Macdonald TT (2010) Curcumin as a therapeutic agent the evidence from in vitro animal and human studies. Br J Nutr 103:1545–1557</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20100380</ArticleId>
            <ArticleId IdType="doi">10.1017/S0007114509993667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bronte E, Coppola G, Miceli RD, Sucato V, Novo RA, S, (2013) Role of curcumin in idiopathic pulmonary arterial hypertension treatment: A new therapeutic possibility. Med Hypothesis 81:923</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mehy.2013.08.016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chiu Z, Khan ZA, Farhangkhoee H, Chakrabarti S (2009) Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB. Nutrition 25:964–972</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19268536</ArticleId>
            <ArticleId IdType="doi">10.1016/j.nut.2008.12.007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soetikno V, Watanabe K, Sari FR, Harima M, Thandavarayan RA, Veeraveedu PT et al (2011) Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type 1 diabetic rats. Mol Nutri Food Res 55:1655–1665</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mnfr.201100080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soetikno V, Sari FR, Veeraveedu PT, Thandavarayan RA, Harima M, Sukrumaran V, Lakshmanan AP, Suzuki K, Kawachi H, Watanabe K (2011) Curcumin ameliorates, macrophage infiltration by inhibiting NF-ƙB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy. Nutri Metabol 8:35</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1743-7075-8-35</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan Y, Zhu G, Wang Y, Cai I, Cai Y, Hu J, Li Y, Yan Y, Wang Z, Li X, Wei T, Liang G (2013) Attenuation of high-glucose-induced inflammatory response by a novel curcumin derivative B06 contributes to its protection from diabetic pathogenic changes in rat kidney and heart. J Nutr Biochem 24:146–155</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22819547</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jnutbio.2012.03.012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan Y, Zhu G, Wang Y, Cai L, Cai Y, Hu J, Li Y, Yan Y, Wang Z, Li X, Wei T, Liang G (2012) Inhibition of high glucose induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats. Br J Pharmacol 166:1169–1182</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22242942</ArticleId>
            <ArticleId IdType="pmc">3417437</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1476-5381.2012.01854.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murugan P, Pari L (2006) Influence of tetrahydrocurcumin on hepatic and renal functional markets and protein levels in experimental type 2 diabetic rats. Bas Clinic Pharmacol Toxicol 101:241–245</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1742-7843.2007.00109.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Molina-Jijon E, Tapia E, Zazueta C et al (2011) Curcumin prevents Cr (VI)-induced renal oxidant damage by mitochondrial pathway. Free Radic Biol Med 51:1543–1557</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21839166</ArticleId>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2011.07.018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong TY, Klein R, Barbara E, Klein K et al (2001) Retinal microvascular abnormalities and their relationship with hypertension cardiovascular disease and mortality. Surv Ophthalmology 46:59–79</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0039-6257(01)00234-X</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hirose F, Kiryu J, Miyamoto K et al (2004) In vivo evaluation of retinal injury after transient ischemia in hypertensive rats. Hypertension 43:1098–1102</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15007035</ArticleId>
            <ArticleId IdType="doi">10.1161/01.HYP.0000123069.02156.8a</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okuno S, Saito A, Hayashi T et al (2004) The c-Jun N-terminal protein kinase signaling pathway mediates Bax activation and subsequent neuronal apoptosis through interaction with Bim after transient focal cerebral ischemia. J Neurosci 24:7879–7987</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15356200</ArticleId>
            <ArticleId IdType="pmc">6729938</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.1745-04.2004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aggarwal BB, Banerjee S, Bharadwaj U et al (2007) Curcumin induces the degradation of cyclin E expression through ubiquitin dependent pathway and up-regulates cyclindependent kinase inhibitors p21 abd p 27 in multiple human tumor cell lines. Biochem Pharmacol 73:1024–1032</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17240359</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bcp.2006.12.010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan J, Li X, Yan Y et al (2012) Curcumin attenuates rat thoracic aortic aneuryam formation by inhibition of the c-jun N-terminal kinase pathway and apoptosis. Nutrition 28:1068–1074</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22840386</ArticleId>
            <ArticleId IdType="doi">10.1016/j.nut.2012.02.006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li JL, Fan YY, Ye GH, Dong MW, Lin KZ, Li F, Yu LS (2014) Study on the mechanism of how curcumin improves pulmonary vascular remodeling associated with cronic pulmonary arterial hypertension. Zhongguo Ying Yong Sheng Li Xue Za Zhi 30:451–455</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25571640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Willis AI, Pierre-paul D, Sumpio BE, Gahtan V (2004) Vascular smooth muscle cell migration: Current research and clinical implications. Vasc Endovascular Surg 38:11–23</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14760473</ArticleId>
            <ArticleId IdType="doi">10.1177/153857440403800102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tajsic T, Morrell NW (2011) Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension. Compr Physiol 1:295–317</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23737174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han Y, Sun HJ, Tong Y, Chen YZ, Ye C, Qiu Y, Zhang F, Chen AD, Qi XH, Li YH, Kang YM, Zhu GQ (2019) Curcumin attenuates migration of vascular smooth muscle cells via inhibiting NFƙB-medicated NLRP3 expression in spontaneously hypertensive rats. J Nutr Biochem 72:108212</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31473513</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jnutbio.2019.07.003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soares MP, Seldon MP, Gregoire IP et al (2004) Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol 172:3553–3563</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15004156</ArticleId>
            <ArticleId IdType="doi">10.4049/jimmunol.172.6.3553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wongeakin N, Bhattaraksol P, Patumraj S (2014) Molecular mechanisms of curcumin on diabetes induced endothelial dysfunction Txnip, ICAM-1 and NOX-2 expression. Biomed Res Int 161346</Citation>
        </Reference>
        <Reference>
          <Citation>Fleenor BS, Swindler AL, Marvi NK et al (2013) Curcumin ameliorates arterial dysfunction and oxidative stress with aging. Exp Geronol 48:269–276</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.exger.2012.10.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carranza A, Litterio MC, Prince PD et al (2011) Lipopolysaccharide (LPS) induction of nitric oxide synthase-2 and cyclooxygenase-2 is impaired in fructose overloaded rats. Life Sci 88:307–313</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21146548</ArticleId>
            <ArticleId IdType="doi">10.1016/j.lfs.2010.12.005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel J, Iyer A, Brown L (2009) Evaluation of the chronic complications of diabetes in a high fructose diet in rats. Indian J Biochem Biophys 46:66–72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19374256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oudot A, Behr-Roussel D, Le Coz O et al (2010) How does chronic sildenafil prevents vascular, oxidative stress in insulin-resistant rats? J Sex Med 7:79–88</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19845545</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1743-6109.2009.01551.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rebolledo A, Robolledo OR, Marra CA et al (2010) Early alterations in vascular contractility associated to changes in fatty acid composition and oxidative stress markers in perivascular adipose tissue. Cardiovasc Diabetol 9:1–13</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1475-2840-9-65</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El-Bassossy HM, El-Maraghy NN, El-Fayoumi HM, Watson ML (2009) Heme oxygenase-1 induction protects against tumor necrosis factor alpha impairment of endothelial-dependent relaxation in rat isolated pulmonary artery. Br J Pharmacol 158:1527–1535</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19845678</ArticleId>
            <ArticleId IdType="pmc">2795219</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1476-5381.2009.00419.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El-Bassossy HM, El-Moselhy MA, Mahmound MF (2011) Pentoxifylline alleviates vascular impairment in insulin resistance via TNF-α inhibition. Naunyn Schmiedebergs Arch Pharmacol 384:277–285</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21800096</ArticleId>
            <ArticleId IdType="doi">10.1007/s00210-011-0669-z</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mahmoud MF, El-Nagar M, El-Bassossy HM (2012) Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats. Arch Pharm Res 35:155–162</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22297754</ArticleId>
            <ArticleId IdType="doi">10.1007/s12272-012-0117-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Majithiya JB, Balaram R (2005) Time-dependent changes in antioxidant enzymes and vascular reactivity of aorta in streptozotocin-induced diabetic rats treated with curcumin. J Cardiovasc Pharmacol 46:697–705</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16220078</ArticleId>
            <ArticleId IdType="doi">10.1097/01.fjc.0000183720.85014.24</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Majithiya JB, Balaraman R, Giridhar R, Yadav MR (2005) Effect of bis[curcumino]oxovanadium complex on non-diabetic and streptozotocin-induced diabetic rats. J Trace Elem Med Biol 18:211–217</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15966569</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jtemb.2004.12.001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Donaldo JV Jr, Hart GM, Bergstrain EJ et al (1995) Prognostic determinants in lupus nephritis: A long-term clinicopathological study. Lupus 4:109–115</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/096120339500400206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wikiera-Magoft MA, Zwolinska D (2005) Prognostic factors in children with lupus nephritis. Wiad Lek 58:50–54</Citation>
        </Reference>
        <Reference>
          <Citation>Baqi N, Moazami S, Singh A et al (1996) Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. J Am Soc Nephrol 7:924–929</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8793802</ArticleId>
            <ArticleId IdType="doi">10.1681/ASN.V76924</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marini R, Costallat LT (1999) Young age, at onset, renal involvement and arterial hypertension lupus erythematous. Rev Rhum Engl Ed 66:303–309</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10418057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Emre S, Bilgre I, Sirin A et al (2001) Lupus Nephritis in children: prognostic significance of clinicopathological findings. Nephron 87:118–126</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11244305</ArticleId>
            <ArticleId IdType="doi">10.1159/000045899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khajehdehi P, Zanjaninejad B, Aflaki E, Nazarinia M, Azad F, Malekm L (2012) Oral supplementation of turmeric decreases proteinuria, hematuria and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis:a randomized and placebo-controlled study. J Renal Nutri 22:50–57</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.jrn.2011.03.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murugan P, Pari L (2006) Antioxidant effect of tetrahydrocurcumin in streptozocin-nicotinamide induced diabetic rats. Life Sci 79:1720–1728</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16806281</ArticleId>
            <ArticleId IdType="doi">10.1016/j.lfs.2006.06.001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pari l, Amali DR, (2005) Protective role of tetrahydrocurcumin (THC) an active principle of turmeric on chloroquine induced hepatotoxicity in rats. J Pharm Pharm Sci 8:115–123</Citation>
        </Reference>
        <Reference>
          <Citation>Nakmareong S, Kukongviriyapan U, Pakdeechote P, Kukongviriyapan V, Kongyingyoes B, Donpunha W, Prachaney P, Phisalaphong C (2012) Tetrahydrocurcumin alleviates hypertension aortic stiffening and oxidative stress in rats with nitric oxide deficiency. Hypertens Res 35:418–425</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22072109</ArticleId>
            <ArticleId IdType="doi">10.1038/hr.2011.180</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan MH, Lin-shiau SY, Lin JK (2000) Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages. Biochem Pharmacol 60:1665–1676</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11077049</ArticleId>
            <ArticleId IdType="doi">10.1016/S0006-2952(00)00489-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gauss KA, Nelson-Overton LK, Siesme DW, Gao Y, DeLeo FR, Quinn MT (2007) Role of NF-KappaB in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor-alpha. J Leukoc Biol 82:729–741</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17537988</ArticleId>
            <ArticleId IdType="doi">10.1189/jlb.1206735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anarther J, Racchumi G, Ladecola C (2006) NF-KappaB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox. J Biol Chem 281:5657–5667</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M506172200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakmareong S, Kukongviriyapan U, Pahdeechote P, Donpunha W, Kukongviriyapan V, Kongyingyoes B, Sompamit K, Phisalaphong C (2011) Antioxidant and vascular protective effects of curcumin and tetrahydrocurcumin in rats with L-NAME induced hypertension. Naunyn Schimedeberg’s Arch Pharmacol 383:519–529</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00210-011-0624-z</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kitamoto S, Egashira K, Kataoka C, Koyanagi M, Katoh M, Shimokawa H, Morishita R, Kaneda Y, Sueishi K, Takeshita A (2000) Increased activity of nuclear factor-kappaB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats. Circulation 102:806–812</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10942751</ArticleId>
            <ArticleId IdType="doi">10.1161/01.CIR.102.7.806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flammer AJ, Anderson T, Celermajer DS et al (2012) The assessment of endothelial function from research into clinical practice. Circulation 126:753–767</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22869857</ArticleId>
            <ArticleId IdType="pmc">3427943</ArticleId>
            <ArticleId IdType="doi">10.1161/CIRCULATIONAHA.112.093245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raitakari OT, Celermajer DS (2000) Flow mediated dilation. Br J Clin Pharmacol 50:397–404</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11069434</ArticleId>
            <ArticleId IdType="pmc">2014404</ArticleId>
            <ArticleId IdType="doi">10.1046/j.1365-2125.2000.00277.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cooke JP, Rossitch E Jr, Andon NA, Loscalzo J, Dzau VJ (1991) Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest 88:166371</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI115481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kapakos G, Youreva V, Srivastava AK (2012) Cardiovascular protection by curcumin: Molecular aspect. India Biochem Biophys 49:306–315</Citation>
        </Reference>
        <Reference>
          <Citation>Wongcharoen W, Phrommintikul A (2009) The protective role of curcumin in cardiovascular diseases. Int J Cardiol 133:145–151</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19233493</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ijcard.2009.01.073</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moncada S, Higgs EA (1991) Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Investig 21:361–374</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2362.1991.tb01383.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bredt DS, Snyder SH (1994) Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63:175–195</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7526779</ArticleId>
            <ArticleId IdType="doi">10.1146/annurev.bi.63.070194.001135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Motterlini R, Foresti R, Bassi R, Green CJ (2000) Curcumin an antioxidant and anti inflammatory agent, induces heme oxygenase-1 expression and protect endothelial cell againsts oxidative stress. Free Radic Boil Med 28:1303–1312</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0891-5849(00)00294-X</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramaswami G, Chai H, Yao Q, Lin PH, Lumsden AB, Chen C (2004) Curcumin blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. J Vasc Surg 40:1216–1222</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15622377</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jvs.2004.09.021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suphim B, Prawan A, Kukongviriyapan U, Kongpetch S, Buranrat B, Kukongviriyapan V (2010) Redox modulation and human bile duct cancer inhibition by curcumin. Food Chem Toxicol 48:2265–2272</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20510329</ArticleId>
            <ArticleId IdType="doi">10.1016/j.fct.2010.05.059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bengmark S (2006) Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN J Parenter Enteral Nutr 30:45–51</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16387899</ArticleId>
            <ArticleId IdType="doi">10.1177/014860710603000145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome-a new worldwide definition. Lancet 366:1059–1062</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16182882</ArticleId>
            <ArticleId IdType="doi">10.1016/S0140-6736(05)67402-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Balkau B, Charles MA (1999) Comment on the provisional report from the WHO consultation, European Group for the study of insulin Resistance (EGIR). Diabet Med 16:442–443</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10342346</ArticleId>
            <ArticleId IdType="doi">10.1046/j.1464-5491.1999.00059.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Einhorn DR, Cobin GM, Ford RH et al (2003) American college of endocrinology position statement on the insulin resistance syndrome. Endocr Pract 9:237–252</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12924350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C (2004) Definition of metabolic syndrome report of the national heart, lung and blood institute/American heart association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24:e13–e18</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14766739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rungseesantivanson S, Thenchaisri N, Ruangvejvorchai P, Patumraj S (2010) Curcumin supplementation could improve diabetes-induced endothelial dysfunction associated with decreased vascular superoxide production and PKC inhibition. BMC Complement Altern Med 10:1–9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1472-6882-10-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dusing R (2003) Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men. Blood Press 12:S29–S34</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/08038020310021967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mallick C, Mandal S, Barik B, Bhattacharya A, Ghosh D (2007) Protection of testicular dysfucntions by MTEC, a formulation herbal drug, in streptozotocin induced diabetic rat. Bio Pharmaceut Bull 30:84–90</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1248/bpb.30.84</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao H, Xu S, Wang Z, Li Y, Guo W, Lin C, Gong S, Li C, Wang G, Cai L (2010) Repetitive exposures to low-dose X-rays attenuate testicular apoptotic cell death in streptozotocin-induced diabetes rats. Toxicol Lett 192:356–364</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19931367</ArticleId>
            <ArticleId IdType="doi">10.1016/j.toxlet.2009.11.011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azu OO (2015) Testicular morphology in spontaneously hypertensive rat model: oxidant status and stereological implications. Andrologia 47:123–137</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24471984</ArticleId>
            <ArticleId IdType="doi">10.1111/and.12233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adams ML, Nock B, Truong R, Cicero TJ (1992) Nitric oxide control of steroidogenesis: endocrine effects of NG-nitro-L-arginine and comparisons to alcohol. Life Sci 50:PL35–PL40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1734158</ArticleId>
            <ArticleId IdType="doi">10.1016/0024-3205(92)90384-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alvarez JG, Touchstone JC, Blasco L, Storey BT (1987) Spontaneous lipid peroxidation and production of hydrogen peroxide in human spermatozoa. J Androl 8:338–348</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2822642</ArticleId>
            <ArticleId IdType="doi">10.1002/j.1939-4640.1987.tb00973.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCall TB, Broughton-Smith NK, Palmer RMJ (1989) Synthesis of nitric oxide from L-arginine by neutrophils. Biochemical Journal 261:293–296</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2549965</ArticleId>
            <ArticleId IdType="pmc">1138817</ArticleId>
            <ArticleId IdType="doi">10.1042/bj2610293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rm C, Lesczynska-Pikiak L, Abramson SB (1992) Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide production via a direct action on the NADPH oxidase. J Clini Invest 90:1116–1121</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI115929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jeyendran R, van der Ven H, Perez-Pelaez M (1994) Development of an assay to assess the functional intergrity of human sperm membranes and its relationship to other semen characteristics. J Repr Fert 70:219–228</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/jrf.0.0700219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abarikwu SO, Pant AB, Farombi EO (2012) The dietaty antioxidant quercetin protects Sertolli-germcell co-culture from atrazine-induced oxidantive damage. J Biochem Mol Toxicol 26:477–485</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23132811</ArticleId>
            <ArticleId IdType="doi">10.1002/jbt.21449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim YC, Kim JH, Davies MG, Hagen PO, Carson CC 3rd (1995) Modulation of vasoactive intestinal polypeptide (VIP)-mediated relaxation by nitric oxide and prostanoids in the rabbit corpus cavernosum. J Urol 153:8017–8810</Citation>
        </Reference>
        <Reference>
          <Citation>Santillo M, Colantuoni A, Mondola P, Guida B, Damiano S (2015) NOX signalling in molecular ardiovascular mechanisms involved in the blood pressure homeostatsis. Front Physiol 6:194–201</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26217233</ArticleId>
            <ArticleId IdType="pmc">4493385</ArticleId>
            <ArticleId IdType="doi">10.3389/fphys.2015.00194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guimares DD, Carvalho CC, Braga VA (2012) Scavenging of NADPH oxidase–derived superoxide anions improves depressed baroreflex sensitivity in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 39:373–378</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1440-1681.2012.05679.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamanna VS, Ganji SH, Shelkovnikov S, Norris K, Vaziri ND (2012) Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion/infiltration. Am J Nephrol 35:114–119</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22212390</ArticleId>
            <ArticleId IdType="doi">10.1159/000334939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Day SM, Duquaine D, Mundada LV, Menon RV, Khan BV, Rajagopalan S, Fay WP (2003) Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation 107:2601–2606</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12732602</ArticleId>
            <ArticleId IdType="doi">10.1161/01.CIR.0000066910.02844.D0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Higashi Y, Maruhashi T, Noma K, Kihara Y (2014) Oxidative stress and endothelial dysfunction: Clinical evidence and therapeutic implications. Trends Cardiovasc Med 24:165–169</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24373981</ArticleId>
            <ArticleId IdType="doi">10.1016/j.tcm.2013.12.001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite:implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620–1624</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2154753</ArticleId>
            <ArticleId IdType="pmc">53527</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.87.4.1620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu F, Tyml KJ, Wilson X (2008) iNOS expression requires NADPH oxidase dependent redox signalling in microvascular endothelial cells. J Cell Physiol 217:207–214</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18481258</ArticleId>
            <ArticleId IdType="pmc">2551742</ArticleId>
            <ArticleId IdType="doi">10.1002/jcp.21495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Braga VA, Medeiros IA, Riberio TP, Franca-silva MS, Botelho-Ono MS, Guimeares DD (2011) Angiotensin –II-induced reactive oxygen species along the SFO-PVN RVLM pathway implications in neurogenic hypertension. Braz J Med Biol Res 44:871–876</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21755262</ArticleId>
            <ArticleId IdType="doi">10.1590/S0100-879X2011007500088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kukongviriyapan U, Apaijit K, Kukongviriyapan V (2016) Oxidative stress and cardiovascular dysfunction associated with cadmium exposure: Beneficial effects of curcumin and tetrahydrocurcumin. Tohoku J Exp Med 239:25–38</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27151191</ArticleId>
            <ArticleId IdType="doi">10.1620/tjem.239.25</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sangartit W, Ponpunha W, Kukongviriyapan U, Surawattanawan P (2013) Effect of combined tetrahydrocurcumin and deferiprone on oxidative stress and vascular dysfunction in iron overloaded mice. Srinagarind Med J 28:271–275</Citation>
        </Reference>
        <Reference>
          <Citation>Sangartit W, Pakdeechote P, Kukongviriyapan V, Donpunha W, Shibahara S, Kukongviriyapan U (2016) Tetrahydrocurcumin in combination with deferiprone attenuates hypertension vascular dysfunction, baroreflex, dysfunction and oxidative stress in iron-overloaded mice. Vascul Pharmacol 87:199–208</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27713040</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vph.2016.10.001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fresquet FF, Pourageaud V, Leblais RP et al (2006) Role of reactive oxygen species and gp91phox in endothelial dysfunction of pulmonary arteries induced by chronic hypoxia. Br J Pharmacol 148:714–723</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16715116</ArticleId>
            <ArticleId IdType="pmc">1751862</ArticleId>
            <ArticleId IdType="doi">10.1038/sj.bjp.0706779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wedgwood S, Black SM (2005) Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor –mediated generation of hydrogen peroxide. Am J Physiol Lung Cell Mol Physiol 288:L480–L487</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15531748</ArticleId>
            <ArticleId IdType="doi">10.1152/ajplung.00283.2004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Devadasu VR, Wadsworth RM, Ravi Kumar MNV (2011) Tissue localization of nanoparticles is altered due to hypoxia resulting in poor efficacy of curcumin nanoparticle in pulmonary hypertension. Eur J Pharm Biopharm 80:578–584</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22227367</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ejpb.2011.12.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ungvari Z, Csiszar A, Huang A, Kaminski PM, Wolin MS, Koller A (2003) High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase. Circulation 108:1253–1258</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12874194</ArticleId>
            <ArticleId IdType="doi">10.1161/01.CIR.0000079165.84309.4D</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Q, Taylor WR, Harrison DG, de Leon H, Wilcox JN, Griendling KK (1997) p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 80:45–51</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8978321</ArticleId>
            <ArticleId IdType="doi">10.1161/01.RES.80.1.45</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zalba G, José GS, Moreno MU, Fortuño MA, Fortuño A, Beaumont FJ, Díez J (2001) Oxidative Stress in Arterial Hypertension: Role of NAD(P)H Oxidase. Hypertension 38:1395–1399</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11751724</ArticleId>
            <ArticleId IdType="doi">10.1161/hy1201.099611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Landmesser U, Spiekermann S, Preuss C, Sorrentino S, Fischer D, Manes C, Mueller M, Drexler H (2007) Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease. Arterioscler Thromb Vasc Biol 27:943–948</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17234726</ArticleId>
            <ArticleId IdType="doi">10.1161/01.ATV.0000258415.32883.bf</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schulz E, Jansen T, Wenzel P, Daiber A, Münzel T (2008) Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 10:1115–1126</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18321209</ArticleId>
            <ArticleId IdType="doi">10.1089/ars.2007.1989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Landmesser U, Dikalov S, Price SR, Mccann L, Fukai T, Holland SM, Mitch WE, Harrison DG (2003) Oxidation of tetrahydrobiopterin leads to uncoupling of enbdothelial cell nitric oxide synthase in hypertension. J Clin Investing 111:1201–1209</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI200314172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide and peroxynitrite: the good, the bad and ugly. Am J Physiol 271:C1424–C1437</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8944624</ArticleId>
            <ArticleId IdType="doi">10.1152/ajpcell.1996.271.5.C1424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manjunatha H, Srinivasan K (2007) Hypolipidemic and antioxidant effects of curcumin and capsaicin in high-fat-fed rats. Can J Physiol Pharmacol 85:588–596</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17823620</ArticleId>
            <ArticleId IdType="doi">10.1139/Y07-044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sompamit K, Kukongviriyapan U, Nakmareong S, Pannangpetch P, Kukongviriyapan V (2009) Curcumin improves vascular function and alleviates oxidative stress in non-lethal lipopolysaccharide-induced endotoxaemia in mice. Eur J Pharmacol 15:192–199</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejphar.2009.06.014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu PH et al (2007) The relaxant effect of curcumin on procine coronary arterial ring segments. Vascul Pharmacol 47:25–30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17459781</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vph.2007.03.003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bouvet C, Gilbert LA, Girardot D, deBlois D, Moreau P (2005) Different involvement of extracellular matrix components in small and large arteries during chronic NO synthase inhibition. Hypertension 45:432–437</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15655118</ArticleId>
            <ArticleId IdType="doi">10.1161/01.HYP.0000154680.44184.01</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Newby AC (2006) Matrix metalloproteinases regulate migration, proliferation and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res 69:614–624</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16266693</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cardiores.2005.08.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castro MM, Rizzi E, Figueriredo-Lopes L, Fernandes K, Bendhack LM, Pitol DL et al (2008) Metalloproteinases inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovasular hypertensive rats. Atherosclerosis 198:320–331</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18054360</ArticleId>
            <ArticleId IdType="doi">10.1016/j.atherosclerosis.2007.10.011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walter A, Etienne-Selloum N, Sari M, Kane MO, Beretz A, Schini-Kerth VB (2008) Angiotensin II induces the vascular expression of VEGF and MMP-2 in vivo-preventive effect of red wine polypherol. Vasc Res 45:386–394</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000121408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lei J, Vodovotz Y, Tzeng E, Billiar TR (2013) Nitric oxide, a protective molecules in the cardiovascular system. Nitric Oxide 35:175–185</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24095696</ArticleId>
            <ArticleId IdType="doi">10.1016/j.niox.2013.09.004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paravicini TM, Touyz RM (2008) NADPH oxidases reactive oxygen species and hypertension clinical implications and therapeutic possibilities. Diabetes Care 31:S170–S180</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18227481</ArticleId>
            <ArticleId IdType="doi">10.2337/dc08-s247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xie J, Hu J, Mao JL (2014) Effects of curcumin on vascular remodeling of rats with spontaneous hypertension. Journal of Shanghai Jiotong University 34:1737–1742</Citation>
        </Reference>
        <Reference>
          <Citation>Chen HW, Huang HC (1998) Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Br J Pharmacol 124:1029–1040</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9720770</ArticleId>
            <ArticleId IdType="pmc">1565483</ArticleId>
            <ArticleId IdType="doi">10.1038/sj.bjp.0701914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Satta J, Juvonen T, Haukipuro K, Juvonen M, Kairaluoma MI (1995) Increased turnover of collagen in abdominal aortic aneurysms, demonstrated by measuring the concentration of the aminoterminal propeptide of type III procollagen in peripheral and aortal blood samples. J Vasc Surg 22:155–160</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7637115</ArticleId>
            <ArticleId IdType="doi">10.1016/S0741-5214(95)70110-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chatziantoniou C, Boffa JJ, Ardaillou R, Dussaule JC (1998) Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin J Clin Invest 101:2780–2789</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9637712</ArticleId>
            <ArticleId IdType="doi">10.1172/JCI2132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sassi ML (2001) Carboxyterminal degradation product of type I collagen. Oulu University Press, Oulu, pp 305–306</Citation>
        </Reference>
        <Reference>
          <Citation>Silver FH, Horvath I, Foran DJ (2001) Viscoelasticity of the vessel wall: the role of collagen and elastic fibers. Crit Rev Biomed Eng 29:279–301</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11730097</ArticleId>
            <ArticleId IdType="doi">10.1615/CritRevBiomedEng.v29.i3.10</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gosline J, Lillie M, Carrington E, Guerette P, Ortlepp C, Savage K (2002) Elastic proteins: biological roles and mechanical properties. Philos Trans R Soc Lond B Biol Sci 357:121–132</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11911769</ArticleId>
            <ArticleId IdType="pmc">1692928</ArticleId>
            <ArticleId IdType="doi">10.1098/rstb.2001.1022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Debelle L, Tamburro AM (1999) Elastin molecular description and function. Int J Biochem Cell Biol 31:261–272</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10216959</ArticleId>
            <ArticleId IdType="doi">10.1016/S1357-2725(98)00098-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keeley FW, Alatawi A (1991) Response of aortic elastin synthesis and accumulation to developing hypertension and the inhibitory effect of colchicine on this response. Lab Invest 64:499–507</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2016856</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Camacho-Barquero L, Vellegas I, Sanchez-Calvo JM, Talero E, Sanchez-Fidalgo S, Motilva V, Alarcon de la Lastra C (2007) Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int Immunopharmacology 7:333–342</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.intimp.2006.11.006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suresh D, Srinivasan K (2010) Tissue distribution &amp; elimination of capsaicin, piperine &amp; curcumin following oral intake in rats. Indian J Med Res 131:682–691</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20516541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joe B, Lokesh BR (1997) Effect of curcumin and capsaicin on arachidonic acid metabolism and lysosomal enzymes seretion by rat peritoneal macrophages. Lipids 32:1173–1780</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9397403</ArticleId>
            <ArticleId IdType="doi">10.1007/s11745-997-0151-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khalf F, Gressier B, Dine T, Brunet C, Luyckx M, Ballester L, Cazin M, Cazin JC (1998) Verapamil inhibits elastase release and superoxide anion production in human neutrophils. Biol Pharm Bull 21:109–112</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1248/bpb.21.109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shapiro SD (1998) Matrix metalloproteinase degradation of extracellular matrix biological consequences. Curr Opin Cell Biol 8:57–64</Citation>
        </Reference>
        <Reference>
          <Citation>Liu Y, Dolence J, Ren J, Rao M, Sreejayan N (2008) Inhibitory effect of dehydrozingererone on vascular smooth muscle cell function. J Cardiovasc Pharmacol 52:422–429</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19033821</ArticleId>
            <ArticleId IdType="doi">10.1097/FJC.0b013e31818aed93</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chakravarti NKH, Yoon DJ, Shay JW, Lotan D, Soneberg N, Lotan R (2010) Differential inhibition of protein translation machinery by curcumin in normal, immortalized and malignant oral epithelial cells. Cancer Prev Res 3:331–332</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1940-6207.CAPR-09-0076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hlavackova L, Janegova A, Ulicna O, Janega P, Cerna A, Babal P (2011) Spice up the hypertension diet-curcumin and piperine prevent remodelling of aorta in experimental L-NAME induced hypertension. Nutri Metabol 8:72</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1743-7075-8-72</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL (1991) Calcineurin is a common target of cyclophilin: cyclosporin A and FKBP-FK 506 complexes. Cell 66:807–815</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1715244</ArticleId>
            <ArticleId IdType="doi">10.1016/0092-8674(91)90124-H</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lopez-Ongil S, Hernandez-Perera O, Navarro-Antolin J, Perez de Lema G, Rodriguez-Puyol M, Lamas S, Rodrı´guez-Puyol D, (1998) Role of reactive oxygen species in the signalling cascade of cyclosporin A-mediated up-regulation of eNOS in vascular endothelial cells. Br J Pharmacol 124:447–454</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9647467</ArticleId>
            <ArticleId IdType="pmc">1565404</ArticleId>
            <ArticleId IdType="doi">10.1038/sj.bjp.0701847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sagiroglu T, Kanter M, Ali Yagci M, Sezer A, Erboga M (2014) Protective effect of curcumin on cyclosporine-A induced endothelial and dysfunction, antioxidant capacity and oxidative damage. Toxicol Ind Health 30:316–327</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22903178</ArticleId>
            <ArticleId IdType="doi">10.1177/0748233712456065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ling Y et al (2012) Changing demographics epidemiology and survival of incident pulmonary arterial hypetension results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med 186:790–796</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22798320</ArticleId>
            <ArticleId IdType="doi">10.1164/rccm.201203-0383OC</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barst RJ et al (2004) Diagnosis and differential assiessment of pulmonary arterial hypertension. J Am Coll Cardiol 43(suppl 12S):40S-47S</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15194177</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jacc.2004.02.032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scipioni A et al (2009) Immunohistochemical localisation of PDE5 in rat lung during pre and postanal development. J Biomed Biotechnol. https://doi.org/10.1155/2009/932961</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2009/932961</ArticleId>
            <ArticleId IdType="pubmed">19707527</ArticleId>
            <ArticleId IdType="pmc">2730472</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schoeffer P et al (1987) Role of cyclic AMP and cyclic GMP phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors. Biochem Pharmacol 36:3965–3972</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0006-2952(87)90465-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galie N et al (2004) Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatmen of pulmonary arterial hypertension of the European society of cardiology. Eur Heart J 25:2243–2278</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15589643</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ehj.2004.09.014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chrysant SG (2013) Effectiveness and safety of phosdiesterase 5 inhibitors in patients with cardiovascular disease and hypertension. Curr Hypertens Rep 15:475–483</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23917809</ArticleId>
            <ArticleId IdType="doi">10.1007/s11906-013-0377-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mochida H et al (2002) Sildenafil and T-1032 phosphodiesterase type 5 inhibitors showed a different vasorelaxant property in the isolated rat aorta. Eur J Pharmacol 440:45–52</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11959087</ArticleId>
            <ArticleId IdType="doi">10.1016/S0014-2999(02)01339-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Briones AM, Rodriguez-Criado N, Hernanz R, Garcia-Redondo AB, Rodrigues RR (2009) Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress. Hypertension 54:142–149</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19451411</ArticleId>
            <ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.109.133710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sarr M, Chataigneau M, Martins S, Schott C, Beoui JEI, Oak MH et al (2006) Red wine polyphenols prevent angiotensin II induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase. Cardiovasc Res 71:794–802</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16822492</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cardiores.2006.05.022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marrinez MI, Castro MM, Rizzi E, Fernandes K, Demacq C, Bendhack LM et al (2008) Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats. Eur J Pharmacol 591:224–230</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejphar.2008.06.096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hijriani N, Yusetyani L, Hasmono D (2020) The effect of Curcuma (Curcuma xanthorrizha roxb.) extract as an adjuvant of captopril therapy on cardiac histopathology of male mice (Mus musculus) with hypertension. J Basic Clin Physiol Pharmacol 30:20190280</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1515/jbcpp-2019-0280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rachmawati H, Soraya IS, Kurniati N, Rahma A (2016) In-vitro study on antihypertensive and antihypercholsterolemic effects of a curcumin nanoemulsion. Sci Pharm 84:131–140</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27110504</ArticleId>
            <ArticleId IdType="pmc">4839556</ArticleId>
            <ArticleId IdType="doi">10.3797/scipharm.ISP.2015.05</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alajbegovic S et al (2013) Valsartan in the treatment of hypertension. Med Arh 67:174–177</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5455/medarh.2013.67.174-177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Y et al (2013) Curcumin attenuates endothelial cell oxidative stress injury through Notch signaling inhibition. Cell Signal 25:615–629</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23219912</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cellsig.2012.11.025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao Y, Wang W, Li M, Ren H, Chen C, Wang J, Wang WE, Yang J, Zeng C (2016) Curcumin exerts its anti-hypertensive effect by down-regulating the AT<sub>1</sub> receptor in vascular smooth muscle cells. Sci Rep 6:1–8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-016-0001-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Balasuriya BWN, Rupasinghe HPV (2011) Plant flavonoids as angiotensin converting enzyme inhibitors in regulation of hypertension functional foods. Health and Dis 5:172–188</Citation>
        </Reference>
        <Reference>
          <Citation>Bhullar KS et al (2013) Curcumin and its carbocyclic analogue: structure activity in relation to antioxidant and selected biological properties. Molecules 18:5389–5404</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23666006</ArticleId>
            <ArticleId IdType="pmc">6270194</ArticleId>
            <ArticleId IdType="doi">10.3390/molecules18055389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haefliger JA, Meda P, Formenton A, Wiesel P, Zanchi A, Brunner HR, Nicod P, Hayoz D (1999) Aortic connexin43 is decreased during hypertension induced by inhibition of nitric oxide synthase. Arterioscler Thromb Vasc Biol 19:1615–1622</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10397678</ArticleId>
            <ArticleId IdType="doi">10.1161/01.ATV.19.7.1615</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X, Bellamy CO, Bailey MA et al (2009) Angiotensin converting enzyme is a modifier of hypertensive end organ damage. J Biol Chem 284:15564–15572</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19307186</ArticleId>
            <ArticleId IdType="pmc">2708853</ArticleId>
            <ArticleId IdType="doi">10.1074/jbc.M806584200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pari L, Murugan P (2007) Tetrahydrocurcumin prevents brain lipid peroxidation in streptozotocin induced diabetic rats. J Med Food 10:323–329</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17651069</ArticleId>
            <ArticleId IdType="doi">10.1089/jmf.2006.058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fazal Y, Fatima SN, Shahid SM, Mahboob T (2015) Effects of curcumin on angiotensin-converting enzyme gene expression oxidative stress and anti-oxidant status in thioacetamide induced hepatotoxicity. J Renin Angiotensin Aldosterone Syst 16:1046–1051</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25143335</ArticleId>
            <ArticleId IdType="doi">10.1177/1470320314545777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Srivastava G, Mehta JL (2009) Currying the heart: curcumin and cardioprotection. J Cardiovasc Pharmacol Ther 14:22–27</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19153099</ArticleId>
            <ArticleId IdType="doi">10.1177/1074248408329608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fiorillo C, Becatti M, Pensalfini A, Cecchi C, Lanzilao L, Donzelli G, Nassi N, Giannini L, Borchi E, Nassi P (2008) Curcumin protects cardiac cells against ischemia-reperfusion injury; Effects on oxidative stress, NF-KappaB, and JNK pathways. Free Radiac Biol Med 45:839–846</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2008.06.013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perez-Torres I, Ruiz-Ramirez A, Banos G, El-Hafidi M (2013) Hibiscus sabdariffa Linnaeus (Malvaceae), Curcumin and Resveratrol as alternative medicinal agents against metabolic syndrome. Cardiovasc Hematol Agents in Med Chem 11:25–37</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1871525711311010006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh VP, Bali A, Singh N, Jaggi AS (2014) Advanced Glycation End Products and Diabetic Complications. Korean J Physiol Pharmacol 18:1–14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24634591</ArticleId>
            <ArticleId IdType="pmc">3951818</ArticleId>
            <ArticleId IdType="doi">10.4196/kjpp.2014.18.1.1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barnett AH (1994) Diabetes and Hypertension. Br Med Bull 50:397–407</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8205465</ArticleId>
            <ArticleId IdType="doi">10.1093/oxfordjournals.bmb.a072899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kshirsagar AV, Joy MS, Hogan SL, Falk RJ (2000) Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: A systematic overview of randomized placebo-controlled trials. Am J Kid Dis 35:695–707</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10739792</ArticleId>
            <ArticleId IdType="doi">10.1016/S0272-6386(00)70018-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lekshmi PC, Arimboor R, Nisha VM, Nirmala Menon A, Raghu KG (2014) In-vitro antidiabetic and inhibitiory potential of turmeric (Curcuma longa L) rhizome against cellular and LDL oxidation and angiotensin converting enzymes. J Food Sci Technol 51:3910–3917</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25477660</ArticleId>
            <ArticleId IdType="doi">10.1007/s13197-013-0953-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang HC, Jan TR, Yeh SF (1992) Inhibitory effect of curcumin, an anti-inflammatory agent, on vascular smooth muscle cell proliferation. Euro J Pharmacol 221:381–384</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0014-2999(92)90727-L</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li M, Wu Z et al (2014) The protective effect of curcumin against the 19-kDa mycobacterium tuberculosis protein induced inflammation and apoptosis in human macrophages Moi Med Rep 10:3261–3267</Citation>
        </Reference>
        <Reference>
          <Citation>Asari Y, Yamaski Y, Tsuchida K, Suzuki K, Akashi YJ, Okazaki T, Ozaki S, Yamada H, Kawahata K (2018) Hemodynamic heterogeneity of connective tissue disease patients with borderline mean pulmonary artery pressure and its distinctive characters from those with normal pulmonary artery pressure :a retrospective study. Clin Rheumatol 37:3373–3380</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29777409</ArticleId>
            <ArticleId IdType="doi">10.1007/s10067-018-4142-y</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang L, Wei XB, He PC, Feng D, Liu YH, Liu J, Chen JY, Yu DQ, Tan N (2017) Value of pulmonary artery pressure in predicting in hospital and one year mortality after valve replacement surgery in middle aged and aged patients with rheumatic mitral disease: An observational study. BMJ Open 7:1–6</Citation>
        </Reference>
        <Reference>
          <Citation>Guo Y, An B, Lang Z, Zhou F, Zhnag X, Wang H (2010) Effects of curcumin on inhibiting the proliferation of pulmonary artery smooth muscle cells and relieving artery smooth cells and relieving pulmonary arterial hypertension. FARMACIA 68:2</Citation>
        </Reference>
        <Reference>
          <Citation>Jackson WF (2000) Ion channels and vascular tone. Hypertension 35:173–178</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10642294</ArticleId>
            <ArticleId IdType="doi">10.1161/01.HYP.35.1.173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berridge MJ, Bootman MD, Roderick HL (2003) Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4:517–529</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12838335</ArticleId>
            <ArticleId IdType="doi">10.1038/nrm1155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Metzler M et al (2013) Curcumin uptake and metabolism Bio Factors 39:14–20</Citation>
        </Reference>
        <Reference>
          <Citation>Park CB, Ahn CM, Oh S, Kwon D, Cho WC, Shin WS, Cui Y, Park BG, Lee S (2015) Synthesis of alkylsulfonyl and substituted benzenesulfonyl curcumin mimics as dual antagonist of L-type Ca<sup>2+</sup> channel and endothelail A/B<sub>2</sub> receptor. Bioorg Med Chem 23:6673–6682</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26386817</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bmc.2015.09.004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee KU, Lee IK, Han J et al (2005) Effects of recombinant adenovirus mediated uncoupling protein 2 overexpression on endothelial function and apoptosis. Circ Res 96:1200–1207</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15905464</ArticleId>
            <ArticleId IdType="doi">10.1161/01.RES.0000170075.73039.5b</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moohammadaree A, Changtam C, Wicha P, Suksamran A, Tocharus J, Tocharuis C (2015) Mechanism of vasorelaxation induced by Hexahydrocurcumin isolated rat thoracic aorta. Phytother Res 29:1806–1813</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26360646</ArticleId>
            <ArticleId IdType="doi">10.1002/ptr.5448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panahi Y, Kianpour P, Mohtashami R, Jafari R, Simental-Mendia LE, Sahebkar A (2017) Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: a randomized controlled trial. Drug Research 67:244–251</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28158893</ArticleId>
            <ArticleId IdType="doi">10.1055/s-0043-100019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang N, Zhang M, Meng X, Sun B (2020) Effects of curcumin on the pharmacokinetics of amlodipine in rats and its potential mechanism. Pharm Biol 58:465–468</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32432949</ArticleId>
            <ArticleId IdType="pmc">7301706</ArticleId>
            <ArticleId IdType="doi">10.1080/13880209.2020.1764060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sunagawa Y, Morimoto T, Wada H, Takaya T, Katanasala Y, Kawamura T et al (2011) A natural p300-specific histone acetyltranserase inhibitor curcumin in addition to angiotensin converting enzyme inhibitor, exerts beneficial effects on left ventricular systolic function after myocardial infraction in rats. Circ 75:2150–2159</Citation>
        </Reference>
        <Reference>
          <Citation>Panighini A, Duranti E, Santini F, Maffei M, Pizzorusso T, Funel N, Taddei S, Bernardini N, Ippolito C, Virdi A, Costa M (2013) Vascular dysfunction in a mouse model or rett syndrome and effects of curcumin treatment. PLoS ONE 8:e64863</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23705018</ArticleId>
            <ArticleId IdType="pmc">3660336</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0064863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mahmoud MF, Bassossy EI, HM, (2014) Curcumin attenuates fructose-induced vascular dysfunction of isolated rat thoracic aorta rings. Pharm Biol 52:972–977</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24611676</ArticleId>
            <ArticleId IdType="doi">10.3109/13880209.2013.874465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Preez RD, Pahl J, Arora M, Ravi kumar MNV, Brown L, Panchal SK, (2019) Low-dose curcumin nanoparticles normalise blood pressure in male vistar rats with Diet-Induced metabolic syndrome. Nutrients 11:1542</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">6682951</ArticleId>
            <ArticleId IdType="doi">10.3390/nu11071542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van der Loo B, Labugger R, Skepper JN et al (2000) Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med 192:1731–1744</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11120770</ArticleId>
            <ArticleId IdType="pmc">2213492</ArticleId>
            <ArticleId IdType="doi">10.1084/jem.192.12.1731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mattiasson G, Sullivan PG (2006) The emerging functions of UCP2 in health disease and therapeutics. Antioxid Redox Signal 8:1–38</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16487034</ArticleId>
            <ArticleId IdType="doi">10.1089/ars.2006.8.1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tian XY, Wong WT, Xu, et al (2012) Uncoupling protein -2 protects endothelial function in diet induced obese mice. Circ Res 110:1211–1216</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22461387</ArticleId>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.111.262170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xie Z, Zhang J, Wu J et al (2008) Upregulation of mitochondrial uncoupling protein -2 by the AMP-activated protein kinase in endothelial cells attenuates oxidative stress in diabetes. Diabetes 57:3222–3230</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18835932</ArticleId>
            <ArticleId IdType="pmc">2584127</ArticleId>
            <ArticleId IdType="doi">10.2337/db08-0610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lan C, Chen X, Wang W, Wang WE, Liu Y, Cai Y, Ren H, Zheng S, Zhou L, Zeng C (2018) Curcumin prevents strokes in stroke-pone spontaneously hypertensive rats by improving vascular endothelial function. BMC Cardiovasc Disord 18:43</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29490624</ArticleId>
            <ArticleId IdType="pmc">5831583</ArticleId>
            <ArticleId IdType="doi">10.1186/s12872-018-0768-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng Z, Yu X, Chen J, Li L, Li S (2014) Curcumin attenuates cardiac fibrosis in spontaneously hypertensive rats through PPAR-γ activation. Acta Pharmacol Sin 35:1247–1256</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25132338</ArticleId>
            <ArticleId IdType="pmc">4186983</ArticleId>
            <ArticleId IdType="doi">10.1038/aps.2014.63</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sola E, Lens S, Guevara M, Martin –Liahi M, Fagundes C, Pereira G, et al (2010) Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension. Hepatology 52:1783–1790</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20931555</ArticleId>
            <ArticleId IdType="doi">10.1002/hep.23893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang HC, Chu CJ, Lee FY, Chang FY, Wang SS, Lin HC et al (2000) Chronic inhibition of nitric oxide ameliorates splanchnic hyposenstivity to glypressin in a hemorrhage transfused rat model of portal hypertension. Scand J Gastroenterol 35:1308–1313</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11199372</ArticleId>
            <ArticleId IdType="doi">10.1080/003655200453674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iwakiri Y, Shah V, Rockey DC (2014) Vascular pathobiology in chronic liver disease and cirrhosis-current status and future directions. J Hepatol 61:912–924</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24911462</ArticleId>
            <ArticleId IdType="pmc">4346093</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jhep.2014.05.047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang F, Zhang Z, Chen L, Kong D, Zhang X, Lu C et al (2014) Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells. J Cell Med 18:1392–1406</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jcmm.12286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao Q, Lin Y, Li-X SX, Wang J, Tu C (2013) Curcumin ameliorates intrapatic angiogenesis and capullarization of the sinusoids in carbon tetrachloride induced rat liver fibrosis. Toxicol Lett 222:72–82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23845850</ArticleId>
            <ArticleId IdType="doi">10.1016/j.toxlet.2013.06.240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernandez M, Vizzutti F, Garcia–pagan JC, Rodes J, Bosch J, (2004) Anti VEGF receptor -2 monoclonal antibody prevents portal systemic collateral vessel formation in portal hypertensive mice. Gastroenterology 126:886–894</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14988842</ArticleId>
            <ArticleId IdType="doi">10.1053/j.gastro.2003.12.012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pantazis P, Varman A, Simpson-Durant C, Thorpe J, Ramalingam S, Subramaniam D et al (2010) Curcumin and turmeric attenuates arcenic indued angiogenesis in vivo. Altern Ther Health Med 16:12–14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20232614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ejaz A, Wu D, Kwan P, Meydani M (2009) Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr 139:919–925</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19297423</ArticleId>
            <ArticleId IdType="doi">10.3945/jn.108.100966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zachary I, Gliki G (2001) Signalling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 49:568–581</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11166270</ArticleId>
            <ArticleId IdType="doi">10.1016/S0008-6363(00)00268-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aggarwal BB, Sung B (2009) Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 30:85–94</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19110321</ArticleId>
            <ArticleId IdType="doi">10.1016/j.tips.2008.11.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karatepe O, Gulcicek OB, Ugurlucan M, Adas G, Battal M, Kemik A et al (2009) Curcumin nutrition for the prevention of mesenteric ischemia reperfusion injury:an experimental rodent model. Transpalent Proc 41:3611–3616</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.transproceed.2009.08.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsu SJ, Lee JY, Lin TY, Hsieh YH, Huang HC, Lee FY, Lin HC, Hou MC, Lee SD (2017) The beneficial effects of curcumin in cirrhotic rats with portal hypertension. Biosci Rep 37:20171015</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BSR20171015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Price LC, Wort SJ, Perros F et al (2012) Inflammation in pulmonary arterial hypertension. Chest 141:210–221</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22215829</ArticleId>
            <ArticleId IdType="doi">10.1378/chest.11-0793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schermuly RT, Ghofrani HA, Wilkins MR, Grimminger F (2011) Mechanisms of disease: pulmonary arterial hypertension. Nat Rev Cardiol 8:442–455</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrcardio.2011.87</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rabinovitch M (2008) Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 118:2372–2379</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18596905</ArticleId>
            <ArticleId IdType="pmc">2439479</ArticleId>
            <ArticleId IdType="doi">10.1172/JCI33452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McLaughlin VV, Davis M, Cornewell W (2011) Pulmonary arterial hypertension. Curr Probl Cardiol 36:461–571</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22035608</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cpcardiol.2011.08.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bharti AC, Donato N, Aggarwal BB (2003) Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol 171:3863–3871</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14500688</ArticleId>
            <ArticleId IdType="doi">10.4049/jimmunol.171.7.3863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou H, Beevers CS, Huang S (2011) The targets of curcumin. Curr Drug Targets 12:332–347</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20955148</ArticleId>
            <ArticleId IdType="pmc">3025067</ArticleId>
            <ArticleId IdType="doi">10.2174/138945011794815356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strimpakos AS, Sharma RA (2008) Curcumin preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal 10:511–545</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18370854</ArticleId>
            <ArticleId IdType="doi">10.1089/ars.2007.1769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abe Y, Hashimoto S, Horie T (1999) Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 30:41–47</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/phrs.1998.0404</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
